HERON THERAPEUTICS, INC. /DE/ Increase (Decrease) in Other Accrued Liabilities
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Increase (Decrease) in Other Accrued Liabilities of $2.18 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccruedLiabilities · last filed 2026-08-10
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in other accrued liabilities for the quarter ending 2026-06-30 was $2.53M.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in other accrued liabilities for the quarter ending 2026-03-31 was -$349.00K, a 106.11% decline year-over-year.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in other accrued liabilities for the quarter ending 2025-12-31 was $3.55M, a 170.63% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in other accrued liabilities for the quarter ending 2025-09-30 was $2.51M.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in other accrued liabilities for fiscal 2025 was $10.60M, a 10607.07% increase from fiscal 2024.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in other accrued liabilities for fiscal 2024 was $99.00K, a 97.04% decline from fiscal 2023.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in other accrued liabilities for fiscal 2023 was $3.34M, a 74.08% decline from fiscal 2022.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in other accrued liabilities for fiscal 2022 was $12.90M.
| Period end | Increase (Decrease) in Other Accrued Liabilities 3 month | Increase (Decrease) in Other Accrued Liabilities 6 month | Increase (Decrease) in Other Accrued Liabilities 9 month | Increase (Decrease) in Other Accrued Liabilities 12 month | Increase (Decrease) in Other Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $2.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $2.18M 10-Q · filed 2026-08-10 | $5.73M derived: sum of 3 quarters · filed 2026-08-10 | $8.24M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2026-03-31 | -$349.00K 10-Q · filed 2026-05-11 | $3.20M derived: sum of 2 quarters · filed 2026-05-11 | $5.71M derived: sum of 3 quarters · filed 2026-05-11 | $4.54M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-12-31 | $3.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.06M derived: sum of 2 quarters · filed 2026-02-26 | $4.89M derived: sum of 3 quarters · filed 2026-08-10 | $10.60M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $2.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $1.34M derived: sum of 2 quarters · filed 2026-08-10 | $7.05M 10-Q · filed 2025-11-04 | $8.36M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-06-30 | -$1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $4.54M 10-Q · filed 2026-08-10 | $5.85M derived: sum of 3 quarters · filed 2026-08-10 | $4.14M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-03-31 | $5.71M 10-Q · filed 2026-05-11 | $7.02M derived: sum of 2 quarters · filed 2026-05-11 | $5.31M derived: sum of 3 quarters · filed 2026-05-11 | $3.81M derived: sum of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$403.00K derived: sum of 2 quarters · filed 2026-02-26 | -$1.91M derived: sum of 3 quarters · filed 2026-02-26 | $99.00K 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$1.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$3.22M derived: sum of 2 quarters · filed 2025-11-04 | -$1.21M 10-Q · filed 2025-11-04 | ||
| 2024-06-30 | -$1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $502.00K 10-Q · filed 2025-08-08 | |||
| 2024-03-31 | $2.00M 10-Q · filed 2025-05-06 | ||||
| 2023-12-31 | $3.34M 10-K · filed 2026-02-26 | ||||
| 2022-12-31 | $12.90M 10-K · filed 2025-02-27 | ||||
| 2021-12-31 | -$7.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$7.31M derived: sum of 2 quarters · filed 2023-03-29 | -$1.75M derived: sum of 3 quarters · filed 2023-03-29 | -$5.26M 10-K · filed 2023-03-29 | |
| 2021-09-30 | -$154.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $5.40M derived: sum of 2 quarters · filed 2021-11-03 | $1.89M 10-Q · filed 2021-11-03 | $8.37M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2021-06-30 | $5.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $2.04M 10-Q · filed 2021-08-09 | $8.53M derived: sum of 3 quarters · filed 2022-02-28 | $6.94M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2021-03-31 | -$3.52M 10-Q · filed 2021-05-10 | $2.97M derived: sum of 2 quarters · filed 2022-02-28 | $1.38M derived: sum of 3 quarters · filed 2022-02-28 | -$7.18M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-12-31 | $6.48M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $4.90M derived: sum of 2 quarters · filed 2022-02-28 | -$3.67M derived: sum of 3 quarters · filed 2022-02-28 | -$6.86M 10-K · filed 2022-02-28 | |
| 2020-09-30 | -$1.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$10.15M derived: sum of 2 quarters · filed 2021-11-03 | -$13.34M 10-Q · filed 2021-11-03 | -$28.47M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-06-30 | -$8.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$11.76M 10-Q · filed 2021-08-09 | -$26.88M derived: sum of 3 quarters · filed 2022-02-28 | -$20.89M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-03-31 | -$3.19M 10-Q · filed 2021-05-10 | -$18.32M derived: sum of 2 quarters · filed 2022-02-28 | -$12.32M derived: sum of 3 quarters · filed 2022-02-28 | -$11.06M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2019-12-31 | -$15.12M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$9.13M derived: sum of 2 quarters · filed 2022-02-28 | -$7.87M derived: sum of 3 quarters · filed 2022-02-28 | $4.56M 10-K · filed 2022-02-28 | |
| 2019-09-30 | $5.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $7.26M derived: sum of 2 quarters · filed 2020-11-05 | $19.68M 10-Q · filed 2020-11-05 | $25.13M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-06-30 | $1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $13.69M 10-Q · filed 2020-08-05 | $19.13M derived: sum of 3 quarters · filed 2021-02-24 | $26.90M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-03-31 | $12.43M 10-Q · filed 2020-05-06 | $17.87M derived: sum of 2 quarters · filed 2021-02-24 | $25.64M derived: sum of 3 quarters · filed 2021-02-24 | $24.79M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2018-12-31 | $5.45M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $13.21M derived: sum of 2 quarters · filed 2021-02-24 | $12.37M derived: sum of 3 quarters · filed 2021-02-24 | $14.94M 10-K · filed 2021-02-24 | |
| 2018-09-30 | $7.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $6.92M derived: sum of 2 quarters · filed 2019-11-12 | $9.49M 10-Q · filed 2019-11-12 | $11.39M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-06-30 | -$843.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $1.73M 10-Q · filed 2019-08-05 | $3.63M derived: sum of 3 quarters · filed 2020-03-02 | $6.97M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-03-31 | $2.57M 10-Q · filed 2019-05-09 | $4.47M derived: sum of 2 quarters · filed 2020-03-02 | $7.82M derived: sum of 3 quarters · filed 2020-03-02 | $12.96M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2017-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $5.25M derived: sum of 2 quarters · filed 2020-03-02 | $10.39M derived: sum of 3 quarters · filed 2020-03-02 | $11.48M 10-K · filed 2020-03-02 | |
| 2017-09-30 | $3.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $8.49M derived: sum of 2 quarters · filed 2018-11-07 | $9.59M 10-Q · filed 2018-11-07 | $12.34M derived: sum of 4 quarters · filed 2019-02-22 | |
| 2017-06-30 | $5.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $6.24M 10-Q · filed 2018-08-08 | $8.99M derived: sum of 3 quarters · filed 2019-02-22 | $10.19M derived: sum of 4 quarters · filed 2019-02-22 | |
| 2017-03-31 | $1.09M 10-Q · filed 2018-05-10 | $3.84M derived: sum of 2 quarters · filed 2019-02-22 | $5.04M derived: sum of 3 quarters · filed 2019-02-22 | $4.42M derived: sum of 4 quarters · filed 2019-02-22 | |
| 2016-12-31 | $2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $3.95M derived: sum of 2 quarters · filed 2019-02-22 | $3.33M derived: sum of 3 quarters · filed 2019-02-22 | $2.48M 10-K · filed 2019-02-22 | |
| 2016-09-30 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $581.00K derived: sum of 2 quarters · filed 2017-11-06 | -$271.00K 10-Q · filed 2017-11-06 | $869.00K derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-06-30 | -$619.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$1.47M 10-Q · filed 2017-08-09 | -$331.00K derived: sum of 3 quarters · filed 2018-02-27 | -$224.00K derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-03-31 | -$852.00K 10-Q · filed 2017-05-10 | $288.00K derived: sum of 2 quarters · filed 2018-02-27 | $395.00K derived: sum of 3 quarters · filed 2018-02-27 | $1.23M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2015-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $1.25M derived: sum of 2 quarters · filed 2018-02-27 | $2.08M derived: sum of 3 quarters · filed 2018-02-27 | $1.55M 10-K · filed 2018-02-27 | |
| 2015-09-30 | $107.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $942.00K derived: sum of 2 quarters · filed 2016-11-08 | $411.00K 10-Q · filed 2016-11-08 | $2.20M derived: sum of 4 quarters · filed 2017-02-23 | |
| 2015-06-30 | $835.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $304.00K 10-Q · filed 2016-08-08 | $2.10M derived: sum of 3 quarters · filed 2017-02-23 | $1.22M derived: sum of 4 quarters · filed 2017-02-23 | |
| 2015-03-31 | -$531.00K 10-Q · filed 2016-05-05 | $1.26M derived: sum of 2 quarters · filed 2017-02-23 | $380.00K derived: sum of 3 quarters · filed 2017-02-23 | $2.07M derived: sum of 4 quarters · filed 2017-02-23 | |
| 2014-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $911.00K derived: sum of 2 quarters · filed 2017-02-23 | $2.60M derived: sum of 3 quarters · filed 2017-02-23 | $2.88M 10-K · filed 2017-02-23 | |
| 2014-09-30 | -$881.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $812.00K derived: sum of 2 quarters · filed 2015-11-06 | $1.08M 10-Q · filed 2015-11-06 | $978.00K derived: sum of 4 quarters · filed 2016-02-19 | |
| 2014-06-30 | $1.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $1.97M 10-Q · filed 2015-08-07 | $1.86M derived: sum of 3 quarters · filed 2016-02-19 | $2.06M derived: sum of 4 quarters · filed 2016-02-19 | |
| 2014-03-31 | $272.00K 10-Q · filed 2015-05-08 | $166.00K derived: sum of 2 quarters · filed 2016-02-19 | $371.00K derived: sum of 3 quarters · filed 2016-02-19 | ||
| 2013-12-31 | -$106.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $99.00K derived: sum of 2 quarters · filed 2016-02-19 | -$36.00K 10-K · filed 2016-02-19 | $1.10M 10-K · filed 2014-03-07 | |
| 2013-09-30 | $205.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $70.00K 10-Q · filed 2014-11-06 | |||
| 2013-06-30 | -$135.00K 10-Q · filed 2014-08-04 | ||||
| 2012-12-31 | $494.00K 10-K · filed 2015-03-13 | $1.10M 10-Q · filed 2013-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |